Dorling Janet 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 27, 2023
Insider Transaction Report
Form 4
Dorling Janet
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-25+25,000→ 25,000 totalExercise: $7.80Exp: 2033-01-24→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly from January 1, 2023.